What's more, by using Kaplan-Meier Plotter dataset (https://kmplot.com/analysis/), we found that patients with high expression of NTF4 have poorer OS and recurrence-free survival (RFS) in Luminal A and and Basal (TNBC) breast cancer, and poorer RFS in HER2-positive breast cancer (p<0.05) (Fig. S2) 24. The gene discussed is ERBB2; the disease is breast carcinoma.